Divi’s Laboratories Investor Relations Material
Latest events
Q3 23/24
Divi’s Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Divi’s Laboratories Limited
Access all reports
DiviS Laboratories Ltd is engaged in the manufacture of Active Pharma Ingredients (APIs) and intermediates. The company offers bulk drug intermediates, APIs, and bulk drug intermediate blends for commercial and laboratory use. DiviS Laboratories' products are used for the synthesis of anti-cancer medicines, anti-infective agents and other pharmaceuticals.
Latest articles
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Companies That Had Their IPO in 2022: War, Inflation and Interest Rates
The stock market and IPO landscape in 2022 was marked by inflationary pressures, rate hikes, and war that heavily impacted the market sentiment.
15 Apr 2024
Ticker symbol
Country
🇮🇳 India